Risk Factors for New-Onset Diabetes Mellitus in Patients Receiving Protease Inhibitor Therapy
BACKGROUND: Metabolic complications including diabetes mellitus (DM) have been associated with protease inhibitor (PI) therapy. Risk factors for the development of DM are not well-defined.
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2005-01-01
|
| Series: | Canadian Journal of Infectious Diseases and Medical Microbiology |
| Online Access: | http://dx.doi.org/10.1155/2005/971971 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832558974709268480 |
|---|---|
| author | Christine A Hughes Richard P Cashin Dean T Eurich Stan Houston |
| author_facet | Christine A Hughes Richard P Cashin Dean T Eurich Stan Houston |
| author_sort | Christine A Hughes |
| collection | DOAJ |
| description | BACKGROUND: Metabolic complications including diabetes mellitus (DM) have been associated with protease inhibitor (PI) therapy. Risk factors for the development of DM are not well-defined. |
| format | Article |
| id | doaj-art-f1aac7c4468a45618e8c8a0b44c7452a |
| institution | Kabale University |
| issn | 1712-9532 |
| language | English |
| publishDate | 2005-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Canadian Journal of Infectious Diseases and Medical Microbiology |
| spelling | doaj-art-f1aac7c4468a45618e8c8a0b44c7452a2025-02-03T01:31:17ZengWileyCanadian Journal of Infectious Diseases and Medical Microbiology1712-95322005-01-0116423023210.1155/2005/971971Risk Factors for New-Onset Diabetes Mellitus in Patients Receiving Protease Inhibitor TherapyChristine A Hughes0Richard P Cashin1Dean T Eurich2Stan Houston3Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, and the Capital Health Region, Edmonton, Alberta, CanadaSaskatoon Health Region, Saskatoon, Saskatchewan, CanadaInstitute of Health Economics and the Department of Public Health Sciences, University of Alberta, CanadaDivision of Infectious Diseases, Department of Medicine, University of Alberta, Edmonton, Alberta, CanadaBACKGROUND: Metabolic complications including diabetes mellitus (DM) have been associated with protease inhibitor (PI) therapy. Risk factors for the development of DM are not well-defined.http://dx.doi.org/10.1155/2005/971971 |
| spellingShingle | Christine A Hughes Richard P Cashin Dean T Eurich Stan Houston Risk Factors for New-Onset Diabetes Mellitus in Patients Receiving Protease Inhibitor Therapy Canadian Journal of Infectious Diseases and Medical Microbiology |
| title | Risk Factors for New-Onset Diabetes Mellitus in Patients Receiving Protease Inhibitor Therapy |
| title_full | Risk Factors for New-Onset Diabetes Mellitus in Patients Receiving Protease Inhibitor Therapy |
| title_fullStr | Risk Factors for New-Onset Diabetes Mellitus in Patients Receiving Protease Inhibitor Therapy |
| title_full_unstemmed | Risk Factors for New-Onset Diabetes Mellitus in Patients Receiving Protease Inhibitor Therapy |
| title_short | Risk Factors for New-Onset Diabetes Mellitus in Patients Receiving Protease Inhibitor Therapy |
| title_sort | risk factors for new onset diabetes mellitus in patients receiving protease inhibitor therapy |
| url | http://dx.doi.org/10.1155/2005/971971 |
| work_keys_str_mv | AT christineahughes riskfactorsfornewonsetdiabetesmellitusinpatientsreceivingproteaseinhibitortherapy AT richardpcashin riskfactorsfornewonsetdiabetesmellitusinpatientsreceivingproteaseinhibitortherapy AT deanteurich riskfactorsfornewonsetdiabetesmellitusinpatientsreceivingproteaseinhibitortherapy AT stanhouston riskfactorsfornewonsetdiabetesmellitusinpatientsreceivingproteaseinhibitortherapy |